Journal
PHYSIOLOGY
Volume 36, Issue 1, Pages 35-43Publisher
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/physiol.00021.2020
Keywords
cardiovascular; circadian rhythm; hypertension; kidney; lung
Categories
Funding
- National Institutes of Health (NIH) [R01DK109570, R21AG052861]
- American Heart Association Postdoctoral Fellowship [18POST34030210]
- American Heart Association [19EIA34660135]
Ask authors/readers for more resources
The peptide hormone endothelin-1 and its receptors are associated with various disease states, such as pulmonary hypertension. While pharmacological inhibition in pulmonary hypertension has been beneficial, further research is needed to leverage the intersection between endothelin signaling and circadian rhythm regulation for potential endothelin-based therapeutics.
The peptide hormone endothelin-1 and its receptors are linked to several disease states. Pharmacological inhibition of this pathway has proven beneficial in pulmonary hypertension, yet its potential in other disease states remains to be realized. This review considers an often understudied aspect of endothelin biology, circadian rhythm regulation and how understanding the intersection between endothelin signaling and the circadian clock may be leveraged to realize the potential of endothelin-based therapeutics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available